Correction: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling

• Tao Xie,
• Du-jiang Fu,
• Zhi-min Li,
• Dao-jun Lv,
• Xian-Lu Song,
• Yu-zhong Yu,
• Chong Wang,
• Kang-jin Li,
• Baoqian Zhai,
• Jiacheng Wu,
• Ning-Han Feng,
• Shan-Chao Zhao

Affiliations

Tao Xie

Department of Urology, Nanfang Hospital, Southern Medical University

Du-jiang Fu

Department of Urology, Nanfang Hospital, Southern Medical University

Zhi-min Li

Department of Urology, Nanfang Hospital, Southern Medical University

Dao-jun Lv

Department of Urology, the Third Affiliated Hospital of Guangzhou Medical University

Xian-Lu Song

Department of Radiotherapy, Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Yu-zhong Yu

Department of Urology, Nanfang Hospital, Southern Medical University

Chong Wang

Department of Urology, Nanfang Hospital, Southern Medical University

Kang-jin Li

Department of Urology, Nanfang Hospital, Southern Medical University

Baoqian Zhai

Department of Radiotherapy Oncology, Yancheng City No.1 People’s Hospital

Jiacheng Wu

Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital

Ning-Han Feng

Department of Urology, Affiliated Wuxi No. 2 Hospital, Nanjing Medical University

Shan-Chao Zhao

Department of Urology, Nanfang Hospital, Southern Medical University